Why the study?
Does the severity of obstructive sleep apnea increase aortic root diameter in hypertensive patients?
Does the severity of obstructive sleep apnea increase aortic root diameter in hypertensive patients?
Answers are grounded in this paper and cite their sources.
While severe OSA is associated with larger absolute and height-corrected aortic root diameters in hypertensive patients, the clinical significance remains uncertain given the low overall prevalence of true aortic dilation.
In this issue of the Journal, Wang et al.1 report the results of a cross-sectional study, carried out in the setting of systemic hypertension, aimed at investigating the association of obstructive sleep apnea (OSA) syndrome with aortic root (AR) diameter, a prognostically validated marker of subclinical vascular damage. Before addressing the main findings and potential implications of the study for clinical practice, as well as its novelty and limitations, some more general considerations on available evidence on this research field and related issues can provide a comprehensive understanding of this important topic. OSA is a highly prevalent complex disorder characterized by an impressive rapid growth incidence worldwide, closely paralleling the epidemic of overweight and obesity in all geographical areas of the world. Much of the morbidity and mortality related to OSA is certainly to be ascribed to an increased burden of cardiovascular disease, including systemic hypertension, arrhythmia, coronary artery disease, and stroke.2 A variety of mechanisms linked to OSA has been identified to unfavorably affect cardiovascular structure and function, resulting in a progressive cardiac and vascular remodeling and, ultimately, in overt cardiovascular disease.3 In patients with OSA repetitive collapses of upper airways lead to intermittent hypoxia, hypercapnia, impaired gas exchange, enhanced sympathetic drive, and sleep disruption. In particular, excessive stimulation of the sympathetic nervous system causes several hemodynamic and metabolic alterations such as hypertension and tachycardia, oxidative stress, insulin resistance, and release of inflammatory substances.4 For over 3 decades, the relationship between OSA and subclinical organ damage (an intermediate step in the cardiovascular continuum linking unhealthy risk factors to cardiovascular events) has been the subject of numerous studies, focusing especially on left ventricular hypertrophy (LVH) in the setting of arterial hypertension.5–7 A recent meta-analysis by our group including 5,550 patients with OSA and 2,329 controls enrolled from 39 studies conducted in 4 different continental areas showed that the prevalence of LVH, as assessed by echocardiography, in the pooled OSA population was markedly high (45%).8 Indeed, the likelihood of having LVH in patients with OSA was 70% greater than non-OSA counterparts. More importantly, these findings documented that the increase in the risk of LVH was closely related to the OSA severity, this is because, regardless of the type of indexation for body size, LV mass index was significantly increased in patients with severe OSA when compared with those with mild OSA as well as non-OSA controls. This was not the case for studies that included cohorts of patients with prevalent mild OSA. A further contribution to this topic was made by another meta-analysis targeting LVH subtypes based on a total of 3,044 patients with and without OSA.9 Concentric LVH was the most common type of hypertrophy in patients with OSA, affecting about a quarter of them, with a concentric to eccentric ratio of approximately 1.5, significantly higher than that observed 0.9 in non-OSA controls (0.9), thus emphasizing that OSA is frequently associated with a particularly high-risk LV geometric pattern. Increasing evidence supports the notion that dilation of the most proximal segment of the systemic arterial tree (i.e., AR), as well as being a risk factor for ascending aortic dissection, may be regarded as a target organ damage paralleling other subclinical markers of established prognostic value. As for AR diameter, its independent value in predicting cardiovascular outcomes has been reported by prospective studies performed in northern American and European community-based samples as well as in hypertensive populations. The Cardiovascular Health Study, the first to open this line of research, including about 4,000 apparently healthy elderly adults at the initial assessment, reported that AR diameter was associated with increased risk of stroke and cardiovascular death (hazard ratios [HRs] 1.3 and 1.6 per 1-cm increase, respectively) at the end of 10 years of follow-up.10 The size of the aortic root and its dilation over time depend on numerous factors including age, gender, anthropometric variables, and cardiovascular risk factors among which hypertension and OSA (which can aggravate or even cause hypertension) stand out.11 All these factors have been supposed to interplay in a complex way in the course of life to affect aortic structure. Since the mid-1980s, the association between OSA and AR diameter (assessed via echocardiography or computed tomography) has been explored by experimental and clinical studies that have hypothesized that this breathing disorder might be one underlying factor for accelerated aortic dilatation. In anesthetized dogs, Peters et al. experimentally induced OSA that led a significant increase in diameter of the intrathoracic aorta of about 6.5%.12 This observation (and others like it) was of clinical relevance as it suggested for the first time a key mechanism underlying aortic dilation in patients with OSA. Clinical research on the impact of OSA on aortic structure started with studies performed in patients with hypermobility syndrome characterized by abnormalities affecting connective tissue in various organs, such as Ehlers–Danlos syndrome, Marfan’s syndrome [MFS]) and osteogenesis imperfecta, all conditions with a particularly high frequency of OSA. A meta-analysis of 13 studies (7 in Ehlers–Danlos syndrome and 6 in MFS patients) showed that the combined prevalence of OSA across both groups was 49%, with a higher rate in MFS patients (60%) than in Ehlers–Danlos syndrome patients (39%).13 Notably, when directly compared with the general population, patients with Ehlers–Danlos syndrome/MFS were on average 6 times more likely to have a diagnosis of OSA. Some cross-sectional studies carried out in MFS found a moderate correlation between the apnea–hypopnea index and maximal AR diameter.14,15 So far, one longitudinal study explored the association between OSA and aortic disease in MFS, without arriving at conclusive results in favor of independent impact on aortic-related events, defined as a progressive aortic dilatation requiring surgery or death due to aortic rupture.16 The association between OSA and the risk of aortic dilation was highlighted in the general population by the Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Ancillary study in which the aortic diameter was measured with magnetic resonance imaging.17 A significant trend of greater mean ascending aortic diameter occurred across the 3 OSA groups: normal (n = 87), mild (n = 215), moderate to severe (n = 406). Surprisingly, most of the numerous studies examining cardiac morphofunctional changes in hypertensive patients with OSA did not provide data on AR diameter and almost none of them enrolled controls without the syndrome.6,8,9 An exception in this regard is the report by Sun et al.18 whose sample included 136 patients with various degrees of OSA and 50 age-matched controls. That study showed that AR diameter was greater in patients with OSA (28.5 ± 2.0 mm) than in controls (27.6 ± 2.1 mm), but with statistical significance borderline after adjustment for confounding factors (0.042). To this scenario, characterized by limited and inconsistent evidence, the findings provided by the present study add a new piece of information focusing on the potential impact of the severity of OSA, as assessed comprehensively by several hypoxia-related parameters, such as apnea–hypopnea index, oxygen desaturation index and time spent with oxygen desaturation less than 90%, and AR diameter.1 The entire study sample consisted of 242 hypertensive patients with OSA of varying severity (52 mild, 71 moderate, and 119 severe), predominantly male (80%), middle aged (50 years), free from known cardiovascular and respiratory disease but with a high prevalence of type 2 diabetes mellitus (20%) and LVH (28%). Patients were classified into 3 groups according to apnea–hypopnea index: mild (5–15/h), moderate (16–30/h), and severe (>30/h). Mean age, gender distribution, height, office systolic and ambulatory blood pressure as well as prevalence of type 2 diabetes, dyslipidemia, and smoking habit were similar in the 3 groups. It is noteworthy that patients with severe OSA had higher body mass index and higher ambulatory diastolic blood pressure values than their counterparts with mild and moderate OSA. As expected, all hypoxia-related parameters were worse in the group of patients with severe OSA. Regarding the outcome of the study, both the absolute AR diameter and the height-corrected AR diameter progressively increased from the mild to moderate and severe OSA group. This, however, was not the case for the AR indexed for body surface area. Finally, it should be noted that no difference in the other echocardiographic parameters (i.e., left atrial diameter, LV wall thickness, LV mass index, prevalence of LVH, systolic/diastolic indexes) emerged in the comparison between the groups. This finding is difficult to explain and not in line with previous evidence obtained in larger populations8,9 although it should be emphasized that the indexation of LV mass for height to allometric power of 2.7 (certainly more appropriate given the high body mass index of this setting) could have revealed significant differences. Despite the fact that Wang et al. suggested that the relationship between the hypoxia-related parameters and AR diameter was independent of several confounding factors and that aortic dilation can be interpreted as an organ damage peculiar to OSA, their data on the prevalence of this phenotype do not allow a final conclusion to be drawn. In fact, AR dilation (assessed by a nonindexed diagnostic criterion: >37 mm in men and >34 mm in women) in the whole sample was approximately 4%, with no differences across the groups. Thus, it seems doubtful that this phenotype can be considered an early and sensitive marker of organ damage, similar to what has already been observed for the general population.19 While acknowledging the merits of the study by Wang et al.,1 further larger studies based on multiple aortic diameter measurements are needed in the future to better delineate the complex relationship between OSA and vascular damage.20 None declared. The authors declared no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Cuspidi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: